Global Automated Breast Ultrasound Systems (ABUS) Market Is Anticipated To Witness Significant Growth Due To Increasing Awareness
Overview:
Automated Breast Ultrasound (ABUS) is a three-dimensional imaging technique that is used as a supplemental screening tool in women with dense breasts. It is a fast and non-invasive way to identify breast cancers early in the life course, before a lump is felt. It is an FDA-cleared supplemental technology for breast screening, and it provides excellent sensitivity, specificity, and radiologist confidence in the detection of asymptomatic cancers in dense tissue.
It can be used as an effective alternative to hand-held ultrasound and improves workflow integration in large volume screening centers. Increasing number of breast cancer cases due to factors such as age, obesity, high alcohol consumption, breast density, exposure to estrogen, and radiation therapy will drive the demand for automated breast ultrasound (ABUS) systems.
Market Dynamics:
Rising product launches are estimated to augment growth of the global Automated Breast Ultrasound Systems (ABUS) Market over the forecast period. For instance, an industry cloud company, Infor launched a new interoperability solution "FHIR Server", for healthcare sector in July 2021. This new solution will help healthcare organizations analyze their data and it is more advanced. Moreover, lack of skilled professionals is anticipated to restrain growth of the global automated breast ultrasound systems (ABUS) for market over the forecast period.
Impact of COVID-19:
COVID-19 was first recognized in 2019 and it was announced as a public health emergency in 2020 by the World Health Organization. The pandemic led to shutting down of trade activities across the world and halting of manufacturing activities in many industries. Almost all sectors of society were affected by the pandemic. The world economy was also affected, several supply chains were disrupted.
Healthcare sector was significantly affected owing to the pandemic. There was a shortage of medical supplies and skilled professionals for attending to the increasing number of COVID-19 patients. This also affected treatment of other diseases. As during the pandemic doctors were prioritizing COVID-19 patients, other treatments were postponed or delayed. This hampered the growth of the global automated breast ultrasound systems (ABUS) for market during the pandemic.
Key Takeaways:
The global Automated Breast Ultrasound Systems (ABUS) Market is expected to witness high growth, exhibiting CAGR of 15.0 % over the forecast period, due to increasing incidences of breast cancer.
For instance, according to the American Cancer Society, almost 287, 850 women were suffering from invasive breast cancer in the United States of America, in 2022. Breast cancer is estimated to cause death of almost 43, 250 women in 2022.
North America is anticipated to witness significant growth in the global automated breast ultrasound systems (ABUS) market over the forecast period, owing to growing presence of major players and increasing incidences of cancer.
Major players operating in the global Automated Breast Ultrasound Systems (ABUS) Market are Seno Medical Instruments Inc., Delphinus Medical Technologies, Inc., Hitachi Ltd., Siemens AG, CapeRay Medical, GE Healthcare, Volpara Solutions Limited, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Metritrack, Inc, Theraclion, and Fukuda Denshi
%20Market.jpg)
Comments
Post a Comment